EXPERIMENTAL DERMATOLOGY, published by WILEY, is a leading journal in the fields of Biochemistry and Dermatology, with impressive rankings including Q1 status in both categories as of 2023. With its ISSN 0906-6705 and E-ISSN 1600-0625, the journal offers a reputable platform for disseminating cutting-edge research and insights into skin biology and related health issues. As a pivotal resource for professionals, researchers, and students alike, EXPERIMENTAL DERMATOLOGY includes a broad scope of topics, fostering a deeper understanding of dermatological conditions and enhancing new therapeutic strategies. The journal’s distinguished performance is highlighted by its Scopus rankings, which place it at the 91st percentile in Medicine-Dermatology and the 65th in Biochemistry. While not an open-access publication, the journal remains committed to ensuring the accessibility of crucial developments within the dermatological community worldwide, facilitating the advancement of both clinical practice and academic inquiry.

Nature Reviews Clinical Oncology is a premier journal dedicated to the comprehensive exploration and critical evaluation of current advancements in the field of clinical oncology. Published by the esteemed NATURE PORTFOLIO in the United Kingdom, this influential journal boasts an impressive impact factor that reflects its significant role in shaping oncology research. As a Q1 ranked journal in Scopus, it occupies a notable position within the top tier of oncology publications, placing it in the 99th percentile among its peers. With a history of convergence from 2009 to 2024, it presents high-quality content through an open-access model, ensuring accessibility to vital research findings. Researchers, professionals, and students alike will find Nature Reviews Clinical Oncology an invaluable resource for staying abreast of the latest trends, biologic insights, and therapeutic innovations that drive the future of cancer treatment.

AKTUELLE DERMATOLOGIE is a distinguished journal in the field of Dermatology, published by GEORG THIEME VERLAG KG in Germany. With a commitment to advancing knowledge and practice in dermatological science, the journal has regularly featured research articles, reviews, and case studies since its inception in 1975 and continues to publish contributions through 2024. Despite being categorized in the lower quartile (Q4) of dermatology journals and holding a Scopus rank of #127 out of 142, it plays a pivotal role in disseminating valuable insights that support ongoing education and research in the discipline. The journal provides an essential platform for both seasoned professionals and budding researchers to share their findings, explore emerging trends, and discuss clinical practices, all while serving the needs of an evolving medical landscape. Access to its content may be restricted, but the journal remains a crucial reference for those invested in the future of dermatological research and patient care.

Turkderm - Turkish Archives of Dermatology and Venerology, published by GALENOS PUBL HOUSE, serves as a vital platform for the dissemination of innovative research and advancements in the fields of dermatology and venerology. With an Open Access policy implemented since 2002, this journal aims to provide free and unrestricted access to significant findings, ensuring that vital information reaches a global audience. Based in Turkey, the journal has positioned itself as an important resource for professionals, researchers, and students alike, despite currently being categorized in Q4 of both Dermatology and Infectious Diseases as per the 2023 metrics. Although it faces competition in the rankings, with a Scopus standing of #131 in Dermatology and #331 in Infectious Diseases, its dedication to advancing knowledge in these critical health areas is unwavering. The journal continually invites original research, reviews, and case studies that enhance clinical practices and foster understanding in the dermatological community.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, published by Mosby-Elsevier, stands at the forefront of dermatological research and education. With an impressive impact factor and categorized as Q1 in Dermatology, this journal has established itself as a pivotal resource for healthcare professionals and researchers in the field. Since its inception in 1979, it has provided a platform for high-quality peer-reviewed articles, contributing significantly to advancements in dermatological science and practice through 2024. The journal commands an honorable position, ranking #8 out of 142 in the Scopus database's medicine dermatology category, placing it in the 94th percentile among its peers. Readers can access a wealth of cutting-edge studies, case reports, and reviews that address a broad spectrum of topics, from clinical dermatology to emerging therapies. In addition, the journal's commitment to excellence ensures it remains an essential tool for students, clinicians, and researchers dedicated to improving skin health and furthering knowledge in dermatology.

INDIAN JOURNAL OF DERMATOLOGY, published by Wolters Kluwer Medknow Publications, is a renowned open-access journal that has been a significant platform for disseminating vital research in the field of dermatology since its inception in 1962. With an ISSN of 0019-5154 and an E-ISSN of 1998-3611, the journal covers a comprehensive array of topics relevant to skin health and diseases, serving both academic and clinical audiences in India and beyond. Having transitioned to an open access model in 2005, it strives to enhance the reach and impact of dermatological research. The journal is classified in the Q3 quartile within the dermatology category as of 2023 and ranks 82 out of 142 in Scopus, showcasing its contribution to the field despite competitive rankings. By fostering scholarly communication and providing a rigorous peer-review process, the INDIAN JOURNAL OF DERMATOLOGY remains a vital resource for researchers, practitioners, and students devoted to advancing the understanding and treatment of skin disorders.

The Journal of Egyptian Women's Dermatological Society, published by Wolters Kluwer Medknow Publications, is an essential platform dedicated to advancing the field of dermatology through a valuable focus on women's health issues. Established to provide an open access outlet since 2019, this journal aims to disseminate research, case studies, and reviews that address the unique dermatological needs and concerns of women, particularly in the Egyptian context. Despite its current ranking in the Q4 category in dermatology and a Scopus rank of #117 out of 142 with a 17th percentile, the journal serves a critical role in fostering scholarly communication among researchers, clinicians, and academicians. With a commitment to promoting knowledge advancement and community engagement, this journal invites submissions that align with its objectives, specifically geared towards empirical research and innovative practices in dermatology impacting women's health.

Journal of Drugs in Dermatology, an esteemed publication in the field of dermatology, serves as a vital resource for researchers, clinicians, and healthcare professionals dedicated to advancing knowledge and practices in skin-related therapies and treatments. Established in 2002 and published in the United States, this journal focuses on a wide range of topics pertinent to dermatological pharmacology and therapeutics, reflecting contemporary scientific advancements and innovative approaches to patient care. With a strong presence in Scopus rankings, situating it at rank #73 within the dermatology category, and achieving a commendable Q2 quartile classification in both dermatology and general medicine categories, the journal is committed to enhancing understanding of drug efficacy and safety in dermatological conditions. While the journal maintains a traditional access model, its impact factor underscores its significance in the research community, supporting the ongoing dialogue between academia and clinical practice. We invite professionals and students alike to explore the latest findings and contribute to the progressive discourse on dermatological treatments through this important publication.

Dermatologica Sinica, published by Wolters Kluwer Medknow Publications, is an esteemed open-access journal in the field of dermatology that has been disseminating critical research since its inception in 2005. With an E-ISSN of 2223-330X and an ISSN of 1027-8117, this journal presents a platform for researchers, clinicians, and students to share cutting-edge findings and advancements in dermatological science. As of 2023, it proudly ranks in the Q2 category of dermatology journals and holds a notable position at rank #62 out of 142 in the Scopus Medicine - Dermatology category, placing it in the 56th percentile for impact. The journal transitioned to an open-access model in 2016, enhancing accessibility and visibility for groundbreaking studies worldwide. With a commitment to fostering innovation in the dermatological community, Dermatologica Sinica aims to advance the understanding and treatment of skin diseases while encouraging scholarly dialogue among practitioners and researchers across the globe.

Cancer Treatment Reviews, published by Elsevier Science Ltd, is a leading international journal dedicated to the exploration and advancement of therapeutic strategies in oncology. With an impressive impact factor that reflects its status in the field, this journal is classified within Q1 quartile rankings in Medicine (Miscellaneous), Oncology, and Radiology, Nuclear Medicine and Imaging, as of 2023. The journal has a rich lineage, having been established in 1974 and consistently evolving to encompass the latest breakthroughs and methodologies in cancer treatment. A vital resource for researchers, clinicians, and students alike, it aims to promote understanding and application of effective interventions, thereby contributing to improvements in patient outcomes. By prioritizing high-quality reviews, Cancer Treatment Reviews plays an essential role in bridging the gap between current research and clinical practice, making it an indispensable asset in the continuous fight against cancer.